S

Surgalign Holdings Inc
F:RT2

Watchlist Manager
Surgalign Holdings Inc
F:RT2
Watchlist
Price: 3.03 EUR -2.73% Market Closed
Market Cap: €20.1m

Surgalign Holdings Inc
Common Stock

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Surgalign Holdings Inc
Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
S
Surgalign Holdings Inc
F:RT2
Common Stock
$10m
CAGR 3-Years
-47%
CAGR 5-Years
-31%
CAGR 10-Years
59%
Haemonetics Corp
NYSE:HAE
Common Stock
$468k
CAGR 3-Years
-2%
CAGR 5-Years
-1%
CAGR 10-Years
-1%
ICU Medical Inc
NASDAQ:ICUI
Common Stock
$2.5m
CAGR 3-Years
1%
CAGR 5-Years
3%
CAGR 10-Years
4%
Align Technology Inc
NASDAQ:ALGN
Common Stock
$7k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Lantheus Holdings Inc
NASDAQ:LNTH
Common Stock
$718k
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
9%
Merit Medical Systems Inc
NASDAQ:MMSI
Common Stock
$747.1m
CAGR 3-Years
4%
CAGR 5-Years
4%
CAGR 10-Years
14%
No Stocks Found

Surgalign Holdings Inc
Glance View

Market Cap
20.1m EUR
Industry
Health Care

Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. The company is headquartered in Deerfield, Illinois and currently employs 231 full-time employees. The company went IPO on 2000-08-10. The firm is focused on developing an augmented reality (AR) and artificial intelligence (AI) digital surgery platform called HOLO AI, which is an artificial intelligence technology being applied to surgery. The technology is designed to automatically segment and identify detailed patient spine anatomy, autonomously create a surgical plan for surgeon review, and then provide visual guidance with augmented reality to the surgeon in the surgical field. The company has a portfolio of spinal hardware implants, including solutions for fusion procedures in the lumbar, thoracic, and cervical spine, motion preservation solutions for the lumbar spine, and a minimally invasive surgical implant system for fusion of the sacroiliac joint. The company also has a biomaterials portfolio of advanced and traditional orthobiologics. The firm offers its products to hospitals, ambulatory surgery centers and healthcare providers in the United States.

RT2 Intrinsic Value
Not Available

See Also

What is Surgalign Holdings Inc's Common Stock?
Common Stock
10m USD

Based on the financial report for Mar 31, 2023, Surgalign Holdings Inc's Common Stock amounts to 10m USD.

What is Surgalign Holdings Inc's Common Stock growth rate?
Common Stock CAGR 10Y
59%

Over the last year, the Common Stock growth was -2%. The average annual Common Stock growth rates for Surgalign Holdings Inc have been -47% over the past three years , -31% over the past five years , and 59% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett